Food and Drug Administration approves first HIV injection

United States: The United States (US) Food and Drug Administration (FDA) has approved the world’s first HIV injection, scientists are calling it a game-changer.

According to the US Food and Drug Administration website, the purpose of the injectable treatment is to ensure a “pre-exposure HIV prevention”. It is hoped that the administration of the drug once every two months will allow ease in contrast to taking a pill daily.

According to a press release, the FDA has approved Apretude (injection) “for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV”.

Insulting the Prophet of Islam is not freedom of expression: Vladimir Putin

Customs arrests importer, court releases same on bail

Prime Minister awards best-performing banks

Trade with China and other countries reduced: Afghanistan

According to reports, at the beginning of this treatment, the drug is supposed to be administered twice to those affected within a gap of thirty days, after which 1 shot is to be administered once every two months.

According to reports, the approval means that patients with HIV will no longer need to take pills such as Truvada and Descovy, which prevent 99% of the spread of HIV through sexual contact, on a regular basis. The process is known as “pre-exposure prophylaxis”. In the United States alone, there are 1.2 million people who have not yet been infected with HIV but may be sexually assaulted.

Local Government Amendment Bill implemented in Sindh

Passengers ship catches fire in Bangladesh; at least 30 dead

Omicron wreaks havoc in the US, dozens of flights canceled

Fear of Omicron: UAE bans four countries

FDA officials say the injection is a more realistic option for groups taking the pill daily, despite its challenges. Problems such as poverty, depression, other medical conditions, and sometimes just forgetfulness can make it difficult to cope with the medication on a daily basis.

Moreover, the safety and efficacy of the drug have been evaluated via two randomized tests. Preliminary experiments showed that Apretude injections were slightly more effective than the drug. In the first trial, 4,600 normal men and transgender women were vaccinated. Sexual intercourse with transgender women was common among men, in which the aptitude vaccine proved to be effective up to 69%.

Food and Drug Administration approves first HIV injection | Baaghi TV

Pilot killed in IAF MiG-21 crash

Muslim youth hung upside down, beaten up by Hindu mob

First CPEC project in Gwadar completed; Locals unaware

Night curfew as Omicron cases rise

In another trial, another 3,200 transgender women received the injection, which showed a 90% protection against HIV. A single dose of injection costs 3,700, while the total cost of six injections is 22,200.

Debra Birnkrant, M.D., director of the Division of Antivirals, FDA has said that the approval “adds an important tool in the effort to end the HIV epidemic”.

Water Taxi will be introduced in Mumbai in 2022

Kylie Jenner hits 292 Million followers on Instagram

146th Birthday of Quaid-e-Azam Muhammad Ali Jinnah

Quaid-e-Azam Day: Guard change ceremony in Karachi

What is the monthly installment for PM’s ‘My Home My Pakistan’ scheme?